Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide is a synthetic small molecule belonging to the benzanilide class of organic compounds. It has the molecular formula C15H13Br2NO2 and a molecular weight of approximately 399.08 Da[1][2][3]. The compound is not approved for clinical use in any country and is classified as experimental[2]. There are no known approved indications or ongoing clinical trials for this molecule. Its mechanism of action has not been fully characterized; however, it has been identified as a ligand that can bind to transthyretin (TTR), a thyroid hormone-binding protein involved in thyroxine transport in humans[2]. No further pharmacological or therapeutic information is available.
- Other names
- Benzamide, N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethyl-N-(3,5-Dibrom-4-hydroxyphenyl)-2,6-dimethylbenzamid
02
Targets
TTR (Transthyretin)
Beyond the preview
Go deeper on N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide.